1-7 of 7
Zachary J Roberts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ALPHA3, a Pivotal Phase 2 Study of First-Line Consolidation with Cemacabtagene Ansegedleucel (Cema-Cel) in Patients with Large B-Cell Lymphoma and Minimal Residual Disease after Response to Standard Therapy

Jason R. Westin, Alex F. Herrera, Ryan Lynch, Jeremy S. Abramson, Don A. Stevens, Matthew Matasar, Lindsey Fitzgerald, Alan P Skarbnik, Chaitanya Iragavarapu, James H Essell, Bradley D. Hunter, Akil Merchant, Indumathy Varadarajan, Anand Tandra, Edward Licitra, Locke Johnson Bryan, Rushang D. Patel, Rajesh Behl, Jeff P. Sharman, Houston Holmes, Habte A. Yimer, Mitul Gandhi, Nosha Farhadfar, Nancy L. Bartlett, Michael Leukam, Tahir Latif, Paolo Caimi, Jean Yared, Amy Feng, Lynn Navale, Sri Ghatta, John B. Le Gall, Zachary J Roberts, John M. Burke
Journal: Blood
Blood (2024) 144 (Supplement 1): 3132.1.
https://doi.org/10.1182/blood-2024-194909
Published: 2024
Journal Articles

Clinical Response after Allogeneic CAR T Cell Therapy Is Linked to Expansion of Identical CD8+ Effector-like T Cell Clones

Andrew P Jallouk, Zhongqi Ge, Vivek Kaimal, Paul B Robbins, Zachary J Roberts, Sattva S. Neelapu, Pavan Bachireddy
Journal: Blood
Blood (2024) 144 (Supplement 1): 4783.
https://doi.org/10.1182/blood-2024-197969
Published: 2024
Journal Articles

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma

Caron A. Jacobson, MD MMSc, Frederick L. Locke, MD, David B. Miklos, MD PhD, Alex F. Herrera, MD, Jason R. Westin, MD, Jennifer Lee, John M. Rossi, MS, Lianqing Zheng, PhD, Mauro P. Avanzi, MD, Zachary J. Roberts, MD, PhD, Jennifer Sun, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4192.
https://doi.org/10.1182/blood-2018-99-111523
Published: 2018
Journal Articles

Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence

Pei-Hsuan Chen, PhD, Mikel Lipschitz, M.S., Kyle Wright, MD, PhD, Philippe Armand, MD PhD, Caron A. Jacobson, MD MMSc, Zachary J. Roberts, MD, PhD, John M. Rossi, MS, Adrian Bot, MD PhD, William Y. Go, MD PhD, Scott J Rodig, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 678.
https://doi.org/10.1182/blood-2018-99-113644
Published: 2018
Journal Articles

Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Brian T. Hill, MD PhD, Zachary J. Roberts, MD PhD, John M. Rossi, MS, Mitchell R. Smith, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2825.
https://doi.org/10.1182/blood.V130.Suppl_1.2825.2825
Published: 2017
Journal Articles

Phase 1 Results from ZUMA-6: Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Frederick L. Locke, MD, Jason R. Westin, MD, David B. Miklos, MD PhD, Alex F. Herrara, MD, Caron A. Jacobson, MD, Jennifer Lee, John M. Rossi, MS, Adrian Bot, MD PhD, Allen Xue, PhD, Lynn Navale, MS, Jeff S. Aycock, Jeffrey S. Wiezorek, MD MS, Zachary J. Roberts, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2826.
https://doi.org/10.1182/blood.V130.Suppl_1.2826.2826
Published: 2017
Journal Articles

Secondary Central Nervous System Lymphoma: A Single Center Experience

Gregory M. Cote, MD, PhD, Yang Feng, PhD, Aliyah R. Sohani, MD, Zachary J. Roberts, MD, PhD, Anna Colpo, MD, Fred H Hochberg, MD, Yi-Bin A. Chen, MD, James S. Michaelson, PhD, Donna Neuberg, ScD, Jeremy S. Abramson, MD, Ephraim P. Hochberg, MD
Journal: Blood
Blood (2011) 118 (21): 5181.
https://doi.org/10.1182/blood.V118.21.5181.5181
Published: 2011